Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
The COVID-19 pandemics has caused the death of almost six million people worldwide. In order to establish collective immunity, the first vaccines that were approved in Germany were the vector virus-based vaccine Vaxzevria and the mRNA vaccines Comirnaty and Spikevax, respectively. As it was reported...
Glavni autori: | , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
MDPI AG
2022-02-01
|
Serija: | Vaccines |
Teme: | |
Online pristup: | https://www.mdpi.com/2076-393X/10/2/333 |